BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1823637)

  • 21. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals.
    Thivolet CH; Tappaz M; Durand A; Petersen J; Stefanutti A; Chatelain P; Vialettes B; Scherbaum W; Orgiazzi J
    Diabetologia; 1992 Jun; 35(6):570-6. PubMed ID: 1612231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Islet cell antibodies].
    Hanafusa T
    Rinsho Byori; 1995 May; 43(5):460-2. PubMed ID: 7783363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Islet cell antibodies, but not glutamic acid decarboxylase antibodies, are decreased by plasmapheresis in patients with newly diagnosed insulin-dependent diabetes mellitus.
    Sundkvist G; Hagopian WA; Landin-Olsson M; Lernmark A; Ohlsson L; Ericsson C; Ahlmén J
    J Clin Endocrinol Metab; 1994 May; 78(5):1159-65. PubMed ID: 8175973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group.
    Knip M; Karjalainen J; Akerblom HK
    Diabetes Care; 1998 Oct; 21(10):1670-3. PubMed ID: 9773728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Islet cell-specific autoantibodies in children with insulin-dependent diabetes mellitus and their siblings at clinical manifestation of the disease. Childhood Diabetes in Finland Study Group.
    Vähäsalo P; Knip M; Karjalainen J; Tuomilehto-Wolf E; Lounamaa R; Akerblom HK
    Eur J Endocrinol; 1996 Dec; 135(6):689-95. PubMed ID: 9025714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay.
    Nakanishi K; Kobayashi T; Miyashita H; Ohkubo M; Sugimoto T; Murase T; Kosaka K; Inouye K; Kono M
    Metabolism; 1990 Sep; 39(9):925-30. PubMed ID: 2202883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children.
    Landin-Olsson M; Karlsson A; Dahlquist G; Blom L; Lernmark A; Sundkvist G
    Diabetologia; 1989 Jun; 32(6):387-95. PubMed ID: 2547682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus: frequency and segregation by age and gender.
    Zimmet PZ; Elliott RB; Mackay IR; Tuomi T; Rowley MJ; Pilcher CC; Knowles WJ
    Diabet Med; 1994 Nov; 11(9):866-71. PubMed ID: 7705024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients.
    Thivolet C; Beaufrère B; Geburher L; Chatelain P; Orgiazzi J; François R
    Diabetologia; 1991 Mar; 34(3):186-91. PubMed ID: 1884891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-37kDa antibodies are associated with the development of IDDM in individuals with islet cell antibodies.
    Ongagna JC; Levy-Marchal C
    Diabetologia; 1995 Mar; 38(3):370-5. PubMed ID: 7758886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.
    Thivolet C; Beaufrére B; Bétuel H; Gebuhrer L; Chatelain P; Durand A; Tourniaire J; François R
    Diabetologia; 1988 Oct; 31(10):741-6. PubMed ID: 3071483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cytoplasmic islet-cell antibodies (ICA) and cytoplasmic complement- fixing antibodies (CF-ICA) in patients with newly detected and short-lasting diabetes mellitus type 1].
    Majkowska L; Czekalski S; Skwira J
    Pol Tyg Lek; 1990 May 7-14; 45(19-20):384-8. PubMed ID: 2255656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of progression to diabetes of low titer ICA-positive first-degree relatives of type I diabetics in southern Germany.
    Ziegler AG; Baumgartl HJ; Standl E; Mehnert H
    J Autoimmun; 1990 Oct; 3(5):619-24. PubMed ID: 2252530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between first-phase insulin secretion and age, HLA, islet cell antibody status, and development of type I diabetes in 220 juvenile first-degree relatives of diabetic patients.
    Robert JJ; Deschamps I; Chevenne D; Roger M; Mogenet A; Boitard C
    Diabetes Care; 1991 Aug; 14(8):718-23. PubMed ID: 1954807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.
    Andersson C; Kolmodin M; Ivarsson SA; Carlsson A; Forsander G; Lindblad B; Ludvigsson J; Kockum I; Marcus C; Samuelsson U; Ortqvist E; Lernmark A; Elding Larsson H; Törn C;
    Pediatr Diabetes; 2014 Aug; 15(5):336-44. PubMed ID: 24206368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
    Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High genetic risk for IDDM in the Pacific Northwest. First report from the Washington State Diabetes Prediction Study.
    Rowe RE; Leech NJ; Nepom GT; McCulloch DK
    Diabetes; 1994 Jan; 43(1):87-94. PubMed ID: 8262322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenetic determinants and prediction of IDDM in French schoolchildren.
    Lévy-Marchal C; Dubois F; Noël M; Tichet J; Czernichow P
    Diabetes; 1995 Sep; 44(9):1029-32. PubMed ID: 7657024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.